Emerald Growth Fund Investor Class FFGRX

Medalist Rating as of | See Emerald Investment Hub
  • NAV / 1-Day Return 23.80  /  +0.51 %
  • Total Assets 1.4B
  • Adj. Expense Ratio
    1.080%
  • Expense Ratio 1.130%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield 0.00
  • Turnover 45%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 1:34 AM GMT+0

Morningstar’s Analysis FFGRX

Will FFGRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Emerald Growth Investor holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FFGRX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 21.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

F/m Emerald Life Sciences Innovation ETF

6.36 91M
—

Travere Therapeutics Inc Ordinary Shares

2.06 30M
Healthcare

InterDigital Inc

2.05 30M
Technology

AAR Corp

1.85 27M
Industrials

VSE Corp

1.78 26M
Industrials

Sensient Technologies Corp

1.74 25M
Basic Materials

Corcept Therapeutics Inc

1.61 23M
Healthcare

Axos Financial Inc

1.51 22M
Financial Services

Mercury Systems Inc

1.51 22M
Industrials

CECO Environmental Corp

1.44 21M
Industrials

Sponsor Center